Hawkins Inc (HWKN)

Hawkins' shares have dropped about 30% from recent peaks, making its valuation more attractive after a period of strong momentum. The company now trades at approximately 23 times realistic earnings, with manageable leverage of 1.3x EBITDA, indicating continued growth through M&A. While organic growth and margin expansion are currently modest, the business remains well-positioned, particularly outside its water treatment segment.

BlackRock Inc. has made a significant new investment of $449.06 million in Hawkins, Inc. (NASDAQ:HWKN), acquiring 3.16 million shares, which represents 15.13% of the specialty chemicals company. This move increases institutional ownership of Hawkins to 69.71%. The investment comes as Hawkins reported mixed quarterly results, with revenue exceeding estimates but earnings per share falling short, and the stock opened near its 52-week low.

Hawkins (NASDAQ:HWKN) recently hit a new 52-week low of $117.82, trading down 0.7% due to mixed analyst sentiment and a slight miss on quarterly EPS expectations, reporting $1.35 against an expected $1.39. Despite the EPS miss, revenue surpassed estimates at $315.68 million, and the company declared a quarterly dividend of $0.19 per share. Analysts currently have an average "Hold" rating on the stock with a consensus price target of $171.

Hawkins Inc. (HWKN) stock reached a new 52-week low of $117.94, marking a 30.37% decline over the past year and a 9.6% drop in the last week. Despite this downturn, the company has maintained dividend payments for 34 consecutive years, and analysts project potential upside with price targets ranging from $142 to $200. Barclays recently initiated coverage with an Equalweight rating and a $170 price target, citing the company's stable position in the water treatment sector.

B. Metzler seel. Sohn & Co. AG has acquired a new stake in Hawkins, Inc. (NASDAQ:HWKN) worth approximately $1.36 million during the second quarter. Other institutional investors have also modified their holdings in the specialty chemicals company. Analysts have issued varied ratings for Hawkins, with an average target price of $171.00, and the company recently declared a quarterly dividend.